BioNTech SE (BNTX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
66.69+3.86 (+6.14%)
At close: 4:00PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 62.83 |
| Open | 61.27 |
| Bid | 66.01 x 800 |
| Ask | 66.80 x 1200 |
| Day's Range | 61.27 - 66.87 |
| 52 Week Range | 12.52 - 105.00 |
| Volume | 1,670,486 |
| Avg. Volume | 3,626,939 |
| Market Cap | 15.884B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Aug 11, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 80.03 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
View moreRelated Research
- Motley Fool
Better Coronavirus Stock: BioNTech or Vir Biotechnology?
Both of these biotechs have promising COVID-19 programs. But one of them appears to have a clear edge.
- MarketWatch
There are four coronavirus vaccines in late-stage studies — here’s how they differ
Johnson & Johnson’s investigational COVID-19 vaccine entered Phase 3 clinical trials this week, making it the fourth vaccine candidate in the U.S. to do so and providing additional details that can help investors differentiate the pool of late-stage coronavirus vaccines.
- Barrons.com
Another Covid-19 Vaccine Candidate Is in the Final Stage of Testing
The company said it will start a 10,000-person trial of its vaccine among volunteers in the U.K. A larger, 30,000-person trial in the U.S. could start in October.
© 2020 Verizon Media. All rights reserved.
